Trial intelligence / Profile preview

Effectiveness of Propolis on Salivary α-Amylase Levels Following Mandibular Third Molar Odontectomy

NCT07907484Completed

Start
Jan 2025
Primary completion
Jul 2025
Countries
1
01

Overview

Randomised trial of propolis 3% spray in Impacted Mandibular Third Molar (IM3M) (2 arms). Primary endpoint: Salivary Alpha-Amylase Concentration at 7 days. Started Jan 2025; status: completed.

02

Drugs

propolis 3% spray
03

Conditions

Impacted Mandibular Third Molar (IM3M)

Beyond the preview

Go deeper on NCT07907484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07907484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call